- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 311/32 - Dérivés dihydro-2, 3, p. ex. flavanones
Détention brevets de la classe C07D 311/32
Brevets de cette classe: 142
Historique des publications depuis 10 ans
|
10
|
9
|
5
|
8
|
10
|
16
|
8
|
11
|
10
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Mcmaster University | 802 |
6 |
| Shanghai Spark Pharmaceutical Co, Ltd | 14 |
5 |
| Suntory Holdings Limited | 2040 |
4 |
| Hefei Lifeon Pharmaceutical Co. Ltd. | 11 |
4 |
| HealthTech Bio Actives, S.L.U. | 26 |
4 |
| Northwestern University | 3398 |
3 |
| Citrox Biosciences Limited | 25 |
3 |
| Firmenich SA | 1686 |
3 |
| Fuso Pharmaceutical Industries, Ltd. | 123 |
3 |
| The Hong Kong Polytechnic University | 472 |
3 |
| Kinki University | 244 |
3 |
| Ingredients by Nature | 4 |
3 |
| Flavocure Biotech, Inc. | 8 |
3 |
| Hoffmann-La Roche Inc. | 3439 |
2 |
| Agency for Science, Technology and Research | 3628 |
2 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 178 |
2 |
| National University Corporation University of Toyama | 170 |
2 |
| Piramal Enterprises Limited | 156 |
2 |
| Pokka Corporation | 10 |
2 |
| Rutgers, The State University of New Jersey | 1893 |
2 |
| Autres propriétaires | 81 |